DK201486A - Mod knogler rettede inhibitorer for kulsyreanhydrase samt fremgangsmaade til fremstilling af disse - Google Patents

Mod knogler rettede inhibitorer for kulsyreanhydrase samt fremgangsmaade til fremstilling af disse Download PDF

Info

Publication number
DK201486A
DK201486A DK201486A DK201486A DK201486A DK 201486 A DK201486 A DK 201486A DK 201486 A DK201486 A DK 201486A DK 201486 A DK201486 A DK 201486A DK 201486 A DK201486 A DK 201486A
Authority
DK
Denmark
Prior art keywords
bone
inhibitors
corrected
procedures
production
Prior art date
Application number
DK201486A
Other languages
Danish (da)
English (en)
Other versions
DK201486D0 (da
Inventor
Jr William M Pierce
Leonard C Waite
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Publication of DK201486D0 publication Critical patent/DK201486D0/da
Publication of DK201486A publication Critical patent/DK201486A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK201486A 1985-05-02 1986-05-01 Mod knogler rettede inhibitorer for kulsyreanhydrase samt fremgangsmaade til fremstilling af disse DK201486A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73087385A 1985-05-02 1985-05-02

Publications (2)

Publication Number Publication Date
DK201486D0 DK201486D0 (da) 1986-05-01
DK201486A true DK201486A (da) 1986-11-04

Family

ID=24937140

Family Applications (1)

Application Number Title Priority Date Filing Date
DK201486A DK201486A (da) 1985-05-02 1986-05-01 Mod knogler rettede inhibitorer for kulsyreanhydrase samt fremgangsmaade til fremstilling af disse

Country Status (10)

Country Link
EP (1) EP0201057B1 (ja)
JP (1) JP2578098B2 (ja)
AT (1) ATE82854T1 (ja)
DE (1) DE3687181T2 (ja)
DK (1) DK201486A (ja)
ES (1) ES8802468A1 (ja)
GR (1) GR861167B (ja)
IE (1) IE59801B1 (ja)
IL (1) IL78661A (ja)
PT (1) PT82499B (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK224589A (da) * 1988-05-09 1989-11-10 Merck & Co Inc Polymalonsyreforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
JPH0778024B2 (ja) * 1988-10-14 1995-08-23 藤沢薬品工業株式会社 医薬化合物とジホスホン酸誘導体の結合体を含有する医薬用製剤
US4990523A (en) * 1989-06-19 1991-02-05 A. H. Robins Company, Incorporated Treatment of chronic inflammatory joint disease with arylsulfonamides
US5183815A (en) * 1991-01-22 1993-02-02 Merck & Co., Inc. Bone acting agents
EP0496520A1 (en) * 1991-01-22 1992-07-29 Merck & Co. Inc. Novel bone acting agents
RU2138507C1 (ru) * 1993-03-25 1999-09-27 Искра Индастри Ко., Лтд. Производные тетрациклина
EP0688787A4 (en) * 1993-12-29 1996-04-17 Iskra Industry Co Ltd MEDICAL COMPOSITION FOR INHIBITING BONE RESORPTION AND ACCELERATING OSTEOGENESIS
US5880111A (en) * 1995-06-07 1999-03-09 Farcasiu; Dan Therapeutic derivations of diphosphonates
EP0981376A1 (en) 1997-02-13 2000-03-01 Bone Care International, Inc. Targeted therapeutic delivery of vitamin d compounds
DE19828068C2 (de) * 1998-06-24 2003-12-18 Peter Dietsch Mittel zur spezifischen Hemmung osteoklastärer Knochenresorption
US6214381B1 (en) 1998-09-08 2001-04-10 Effcon, Inc. Methazolamide composition and method of use
AU4682700A (en) * 1999-04-30 2000-11-17 Research Corporation Technologies, Inc. Bone targeting agents for osteoporosis
US7829074B2 (en) 2001-10-18 2010-11-09 Nektar Therapeutics Hydroxypatite-targeting poly(ethylene glycol) and related polymers
US6436386B1 (en) * 2000-11-14 2002-08-20 Shearwater Corporation Hydroxyapatite-targeting poly (ethylene glycol) and related polymers
US9980946B1 (en) 2017-01-25 2018-05-29 Effcon Laboratories, Inc. Extended release methazolamide formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704383A (en) * 1983-12-29 1987-11-03 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
US4666897A (en) * 1983-12-29 1987-05-19 Research Foundation Of State University Inhibition of mammalian collagenolytic enzymes by tetracyclines
ATE114473T1 (de) * 1984-04-30 1994-12-15 Procter & Gamble Ausrüstung für die verwendung bei der behandlung von osteoporose.

Also Published As

Publication number Publication date
GR861167B (en) 1986-09-30
PT82499B (pt) 1988-10-14
ATE82854T1 (de) 1992-12-15
DE3687181D1 (de) 1993-01-14
IE861148L (en) 1986-11-02
EP0201057B1 (en) 1992-12-02
ES8802468A1 (es) 1988-07-16
IL78661A0 (en) 1986-08-31
JP2578098B2 (ja) 1997-02-05
IE59801B1 (en) 1994-04-06
PT82499A (en) 1986-06-01
JPS6226256A (ja) 1987-02-04
IL78661A (en) 1992-08-18
DE3687181T2 (de) 1993-04-15
EP0201057A2 (en) 1986-11-12
EP0201057A3 (en) 1989-10-18
ES555118A0 (es) 1988-07-16
DK201486D0 (da) 1986-05-01

Similar Documents

Publication Publication Date Title
DK201486A (da) Mod knogler rettede inhibitorer for kulsyreanhydrase samt fremgangsmaade til fremstilling af disse
PL288201A1 (en) Method of obtaining novel derivatives of amino acide
ATE81457T1 (de) Arylamido (und arylthioamido)-azabicycloalkane zur steigerung des erinnerungsvermoegens oder zur behebung von gedaechtnisschwaeche.
MY119155A (en) New peptide derivatives
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
FI925787A (fi) Proteolytiska enzymers sackarinderivatinhibitorer
PH25769A (en) Certain cycloalkane-1,1-diphosphonic acids, derivatives thereof having the ability to treat diseases associated with abnormal calcium, phosphate metabolism
NO302474B1 (no) Sakarinderivater, farmasöytisk sammensetning og anvendelse derav
AU6567086A (en) Compositions and methods for the treatment of bleeding disorders
EP0471756A4 (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof
UA27467C2 (uk) ПОХІДНІ ІНДОЛУ ЯК 5-НТ<sub>1</sub> АГОНІСТИ ТА ПРОМІЖНІ СПОЛУКИ
HUP0002247A2 (hu) Proteáz inhibitorok
EP0727994A4 (en) ANTIPYRETIC AND ANALGESIC METHODS AND COMPOSITIONS CONTAINING OPTICALLY PURE ETODOLIC ACID
AU590172B2 (en) Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
AU2003271811A8 (en) Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulphonates) and compositions containing same
DK174389A (da) Anvendelse af 3-substituerede 2-oxindol-1-carboxamid-forbindelser til fremstilling af farmaceutiske praeparater til inhibering af interleukin-1-biosyntese
IL111580A (en) Use of melatonin derivatives in the preparation of pharmaceutical compositions for use in treating sleep disorders
DK492989D0 (da) Aminopyrrolidinon, farmaceutisk praeparat indeholdende en saadan forbindelse og fremgangsmaade til fremstilling deraf
HU893127D0 (en) Process for the preparation of novel spiro-(imidazolidino-naphtaline) derivatives and pharmaceutical compositions containing such compounds as active ingredient
HUT62303A (en) Process for producing n-substituted aminomethane diphosphonic acids and pharmaceutical compositions comprising same as active ingredient
NO913685D0 (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment